GlassScriptPhysician profile
Dana Joel Eilen
NPI 1407055999
$10,135.81
in general payments reported to CMS, 2019-2025
51 companies · $1,477 in 2025
The $1,477 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,174 · 2020: $1,131 · 2021: $1,417 · 2022: $1,421 · 2023: $2,156 · 2024: $1,360 · 2025: $1,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,153 · Travel and Lodging: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,153.47 |
| Travel and Lodging | $838.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,759.61 | 2019-2024 | Amplatzer Talisman, Mitraclip, Gallant |
| Novartis Pharmaceuticals Corporation | $881.41 | 2019-2025 | |
| Pfizer INC. | $848.09 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $677.71 | 2021-2025 | Verquvo, Capvaxive |
| Janssen Pharmaceuticals, INC | $660.57 | 2019-2024 | Xarelto |
| Amgen INC. | $472.43 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $459.51 | 2019-2024 | Farxiga, Wainua |
| Boston Scientific Corporation | $416.63 | 2019-2025 | Watchman Flx, General - Therapies, Varithena Administration Pack |
| Amarin Pharma, INC. | $395.17 | 2019-2022 | |
| Cvrx, INC. | $323.97 | 2022-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $297.68 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.33 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $225.89 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Actelion Pharmaceuticals US, INC. | $222.89 | 2019-2025 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $199.48 | 2019-2025 | Lifevest |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $192.04 | 2020-2025 | Nexletol |
| Abiomed | $172.06 | 2020-2025 | Impella |
| Atricure, INC. | $164.13 | 2023 | |
| Alnylam Pharmaceuticals INC. | $143.96 | 2021-2025 | Amvuttra, Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $138.44 | 2023-2025 | |
| Inspire Medical Systems, INC. | $124.20 | 2023-2025 | Inspire |
| Astellas Pharma US INC | $112.89 | 2019-2021 | |
| Medtronic, INC. | $109.66 | 2021-2025 | Reveal Linq, Venaseal, Linq II |
| Edwards Lifesciences Corporation | $103.53 | 2020-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Angiodynamics, INC. | $83.45 | 2021 | |
| Sanofi-Aventis U.S. LLC | $64.64 | 2023-2024 | |
| Shockwave Medical, INC | $53.33 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Regeneron Healthcare Solutions, INC. | $51.46 | 2019-2022 | |
| Convatec INC. | $48.77 | 2022-2024 | |
| Lilly USA, LLC | $37.85 | 2024-2025 | Zepbound, Mounjaro |
| Bard Peripheral Vascular, INC. | $36.36 | 2023-2024 | Venclose Maven Catheter |
| Kiniksa Pharmaceuticals, LTD. | $31.37 | 2022-2023 | Arcalyst |
| Medtronic Vascular, INC. | $29.16 | 2020 | |
| Scpharmaceuticals INC. | $28.21 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $26.21 | 2024 | Arcalyst |
| Cardiovascular Systems INC. | $24.42 | 2022 | |
| Elutia, INC. | $23.07 | 2019 | |
| Celgene Corporation | $22.25 | 2024 | Camzyos |
| Bridgebio Pharma, INC. | $22.04 | 2025 | Attruby |
| Lantheus Medical Imaging, INC. | $19.23 | 2023 | Definity |
| Glaxosmithkline, LLC. | $17.57 | 2025 | Shingrix, Arexvy |
| Cardiva Medical, INC. | $16.71 | 2022 | |
| Penumbra, INC. | $16.00 | 2019 | |
| Zoll Circulation INC | $15.00 | 2022 | |
| Philips North America LLC | $14.74 | 2023 | |
| Gilead Sciences, INC. | $13.95 | 2019 | |
| Chiesi USA, INC. | $13.85 | 2019 | |
| Celonova Biosciences, INC. | $13.49 | 2021 | |
| Kestra Medical Technology Services, INC. | $13.09 | 2022 | |
| Arbor Pharmaceuticals, INC. | $11.48 | 2019 | |
| Altathera Pharmaceuticals LLC | $9.83 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Eilen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.